Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis Journal Article


Authors: Nafa, K.; Bessler, M.; Mason, P.; Vulliamy, T.; Hillmen, P.; Castro-Malaspina, H.; Luzzatto, L.
Article Title: Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired chronic hemolytic anemia characterized by intravascular hemolysis, often associated with neutropenia and thrombocytopenia. Venous thrombosis, including the Budd- Chiari syndrome, is one of the major complications of PNH, but not all PNH patients develop thrombosis. The basis for the high risk of thrombosis in PNH is not known. Recent reports have shown that Factor V Leiden mutation is a common cause of increased tendency to develop thrombosis. Fifty-six PNH patients were tested for Factor V Leiden mutation using Amplification Created Restriction Enzyme Site methods. PNH patients do not show an increased frequency of Factor V Leiden mutations.
Keywords: controlled study; major clinical study; mutation; neutropenia; pathophysiology; polymerase chain reaction; thrombocytopenia; vein thrombosis; thrombosis; point mutation; paroxysmal nocturnal hemoglobinuria; hemoglobinuria, paroxysmal; factor v leiden; protein c; thrombophlebitis; oligonucleotide probes; blood clotting factor 5; humans; human; article; activated protein c; factor v
Journal Title: Haematologica
Volume: 81
Issue: 6
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 1996-11-01
Start Page: 540
End Page: 542
Language: English
PUBMED: 9009443
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Citation Impact
MSK Authors
  1. Khedoudja Nafa
    243 Nafa
  2. Lucio Luzzatto
    105 Luzzatto
  3. Monica M. Bessler
    33 Bessler